Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey. Show more
34 Shrewsbury Avenue, Red Bank, NJ, 07701, United States
Start AI Chat
Market Cap
187.4M
52 Wk Range
$0.95 - $9.08
Previous Close
$4.48
Open
$4.48
Volume
622,704
Day Range
$4.36 - $4.79
Enterprise Value
18.78M
Cash
7.61M
Avg Qtr Burn
-1.855M
Insider Ownership
22.66%
Institutional Own.
22.24%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
TH104 Details Primary biliary cholangitis, Chronic pruritus, Liver disease | NDA Submission |